Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
59%
Vaccine Efficacy
58%
Vaccination Policy
46%
Influenza
41%
Viral Disease
31%
Monospecific Antibody
28%
Infectious Agent
27%
Lineages
21%
T Cell
20%
Zoonotic
18%
Immune Response
18%
Human Immunodeficiency Virus 1
18%
Mouse
17%
Human Immunodeficiency Virus
17%
Influenza Virus
17%
Influenzavirus A
17%
Immunogenicity
16%
Omicron Coronavirus Variant
16%
Spike
16%
Neutralizing Antibody
15%
Bird
15%
Mustela Putorius Furo
15%
Norovirus
14%
Coronavirinae
14%
Blood Plasma
13%
Hemagglutinin
13%
Middle East Respiratory Syndrome Coronavirus
12%
Influenza A Virus (H5N1)
12%
Receptor Binding
12%
Neutralization
11%
B Cell
11%
Viral Load
11%
Highly Pathogenic Avian Influenza Virus
11%
Infectious Disease
11%
Viral Replication
10%
Humoral Immunity
10%
Antibody Response
10%
Interferon Type I
10%
Organoid
10%
SARS Coronavirus
10%
Transplant Procedure
10%
Influenza A Virus (H1N1)
9%
Whole Genome Sequencing
9%
Influenza A Virus (H3N2)
9%
Epstein Barr Virus
9%
Arbovirus
9%
Cytokine
9%
Metagenomics
9%
Hepatitis C Virus
8%
Avian Influenza Virus
8%
Usutu Virus
8%
Prevalence
8%
Hepatitis B
8%
Polymerase Chain Reaction
8%
Cladistics
8%
Genetic Variability
8%
Duck
7%
Zika Virus
7%
Human Alphaherpesvirus 1
7%
Respiratory Virus
7%
Phylogeny
7%
West Nile Virus
7%
Virus Transmission
7%
Central Nervous System
7%
Hepatitis B Virus
7%
Measles Virus
7%
Titer
7%
Epitope
7%
Wild Type
7%
Surface Property
6%
Innate Immune System
6%
Flavivirus
6%
Human Metapneumovirus
6%
Varicella Zoster Virus
6%
Molecular Epidemiology
6%
Seroprevalence
6%
Vaccinia Virus
6%
One Health
6%
Canine Distemper Virus
6%
Enterovirus
6%
Antibody Titer
5%
Hemorrhagic Fever
5%
Human Respiratory Syncytial Virus
5%
Measles
5%
Cross-Reactivity
5%
Reverse Transcription Polymerase Chain Reaction
5%
Virus Genome
5%
Lower Respiratory Tract
5%
Monoclonal Antibody
5%
Serology
5%
Adoptive Immunity
5%
Enterovirus D68
5%
Severe Acute Respiratory Syndrome
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
74%
COVID-19
50%
Infection
48%
Human Immunodeficiency Virus
30%
Diseases
22%
Public Health
15%
Symptom
14%
Virus Infection
12%
Pathogen
12%
Antivirus Agent
10%
Diagnosis
10%
Hepatitis C Virus
10%
COVID-19 Vaccination
9%
Men Who Have Sex with Men
9%
Immunogenicity
8%
B Cell
8%
Immune Response
8%
Kidney Graft
8%
Antiretroviral Therapy
8%
Coronavirinae
7%
Omicron Coronavirus Variant
7%
Middle East Respiratory Syndrome Coronavirus
7%
T Cell
7%
COVID-19 Vaccine
6%
Organoid
6%
In Vitro
6%
Thrombosis
6%
Prospective Cohort Study
6%
Cohort Analysis
6%
T-Cell Response
6%
Hepatitis B Virus
5%
Immunocompromised Patient
5%
One Health
5%
Returning Traveler
5%
Virus RNA
5%
Prevalence
5%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
50%
Infection
44%
Disease
35%
HIV
21%
Vaccination Policy
20%
Coronavirinae
16%
Antivirus Agent
14%
Immunogenicity
12%
Virus Infection
11%
Symptom
8%
Mouse
7%
Norovirus
7%
Pandemic
7%
Hepatitis C Virus
6%
Prevalence
6%
COVID-19 Vaccine
6%
Zika Virus
6%
Prospective Cohort Study
6%
Chronic Hepatitis B
6%
Immunocompromised Patient
6%
Biological Marker
5%
Hepatitis B Virus
5%
Clinical Trial
5%
Infectious Agent
5%
Malignant Neoplasm
5%
Zika Fever
5%
Receptor
5%